Strategies for Managing Cytopenias and Infection Prophylaxis with CAR-T Therapy

News
Video

The conversation examines adverse events beyond CRS and neurotoxicities in CAR-T therapy, focusing on strategies for managing prolonged cytopenias, infection prophylaxis, and unique adverse events associated with ide-cel and cilta-cel.

Video content above is prompted by the following:

  • Beyond CRS and neurotoxicities, are there other adverse events that require particular attention?
  • How do you address prolonged cytopenias following CAR-T infusion?
  • What is your approach to infection prophylaxis and management in these patients?
  • Are there any distinct adverse events associated specifically with ide-cel or cilta-cel that clinicians should be aware of?

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
2 experts are featured in this series.
Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
Related Content